Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

NYSE:CXW - New York Stock Exchange, Inc. - US21871N1019 - Common Stock - Currency: USD

22.14  -0.26 (-1.16%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CXW. CXW was compared to 83 industry peers in the Commercial Services & Supplies industry. CXW has an average financial health and profitability rating. CXW has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CXW was profitable.
In the past year CXW had a positive cash flow from operations.
Of the past 5 years CXW 4 years were profitable.
In the past 5 years CXW always reported a positive cash flow from operatings.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

With a Return On Assets value of 2.35%, CXW perfoms like the industry average, outperforming 56.63% of the companies in the same industry.
With a Return On Equity value of 4.61%, CXW perfoms like the industry average, outperforming 57.83% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.17%, CXW is in line with its industry, outperforming 53.01% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CXW is significantly below the industry average of 10.89%.
The 3 year average ROIC (4.72%) for CXW is below the current ROIC(5.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.35%
ROE 4.61%
ROIC 5.17%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

CXW's Profit Margin of 3.51% is in line compared to the rest of the industry. CXW outperforms 59.04% of its industry peers.
CXW's Profit Margin has declined in the last couple of years.
CXW has a better Operating Margin (9.59%) than 68.67% of its industry peers.
In the last couple of years the Operating Margin of CXW has declined.
CXW has a Gross Margin of 23.87%. This is in the lower half of the industry: CXW underperforms 66.27% of its industry peers.
CXW's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.59%
PM (TTM) 3.51%
GM 23.87%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CXW is destroying value.
Compared to 1 year ago, CXW has less shares outstanding
CXW has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CXW has an improved debt to assets ratio.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CXW has an Altman-Z score of 1.85. This is not the best score and indicates that CXW is in the grey zone with still only limited risk for bankruptcy at the moment.
CXW has a Altman-Z score of 1.85. This is in the lower half of the industry: CXW underperforms 60.24% of its industry peers.
The Debt to FCF ratio of CXW is 4.98, which is a neutral value as it means it would take CXW, 4.98 years of fcf income to pay off all of its debts.
CXW's Debt to FCF ratio of 4.98 is fine compared to the rest of the industry. CXW outperforms 69.88% of its industry peers.
CXW has a Debt/Equity ratio of 0.65. This is a neutral value indicating CXW is somewhat dependend on debt financing.
CXW has a Debt to Equity ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.98
Altman-Z 1.85
ROIC/WACC0.63
WACC8.18%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.57 indicates that CXW should not have too much problems paying its short term obligations.
The Current ratio of CXW (1.57) is comparable to the rest of the industry.
CXW has a Quick Ratio of 1.57. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.57, CXW is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.57
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

CXW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.71%, which is quite impressive.
CXW shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.17% yearly.
The Revenue has been growing slightly by 3.43% in the past year.
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)35.71%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%187.5%
Revenue 1Y (TTM)3.43%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%-2.41%

3.2 Future

The Earnings Per Share is expected to grow by 56.89% on average over the next years. This is a very strong growth
CXW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.05% yearly.
EPS Next Y38.55%
EPS Next 2Y56.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.22%
Revenue Next 2Y9.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.13, which means the current valuation is very expensive for CXW.
CXW's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CXW to the average of the S&P500 Index (25.91), we can say CXW is valued inline with the index average.
With a Price/Forward Earnings ratio of 14.74, CXW is valued correctly.
73.49% of the companies in the same industry are more expensive than CXW, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.85. CXW is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 29.13
Fwd PE 14.74
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CXW's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CXW is cheaper than 67.47% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXW indicates a somewhat cheap valuation: CXW is cheaper than 79.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.23
EV/EBITDA 10.52
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CXW's earnings are expected to grow with 56.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y56.89%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CXW!.
Industry RankSector Rank
Dividend Yield N/A

CORECIVIC INC

NYSE:CXW (5/23/2025, 2:31:59 PM)

22.14

-0.26 (-1.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners91.92%
Inst Owner Change-3.81%
Ins Owners1.74%
Ins Owner Change8%
Market Cap2.42B
Analysts82.5
Price Target31.11 (40.51%)
Short Float %3.01%
Short Ratio2.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.04%
Min EPS beat(2)68.32%
Max EPS beat(2)113.77%
EPS beat(4)3
Avg EPS beat(4)41.6%
Min EPS beat(4)-47.19%
Max EPS beat(4)113.77%
EPS beat(8)5
Avg EPS beat(8)21.24%
EPS beat(12)7
Avg EPS beat(12)12.06%
EPS beat(16)9
Avg EPS beat(16)-5.12%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.02%
Max Revenue beat(2)3.59%
Revenue beat(4)4
Avg Revenue beat(4)2.51%
Min Revenue beat(4)0.7%
Max Revenue beat(4)3.73%
Revenue beat(8)5
Avg Revenue beat(8)0.58%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.66%
PT rev (1m)8.54%
PT rev (3m)15.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.65%
EPS NY rev (1m)14.5%
EPS NY rev (3m)22.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 29.13
Fwd PE 14.74
P/S 1.23
P/FCF 12.23
P/OCF 8.99
P/B 1.62
P/tB 1.63
EV/EBITDA 10.52
EPS(TTM)0.76
EY3.43%
EPS(NY)1.5
Fwd EY6.78%
FCF(TTM)1.81
FCFY8.18%
OCF(TTM)2.46
OCFY11.12%
SpS17.94
BVpS13.66
TBVpS13.62
PEG (NY)0.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.35%
ROE 4.61%
ROCE 7.11%
ROIC 5.17%
ROICexc 5.39%
ROICexgc 5.4%
OM 9.59%
PM (TTM) 3.51%
GM 23.87%
FCFM 10.09%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.98
Debt/EBITDA 3.08
Cap/Depr 55.6%
Cap/Sales 3.63%
Interest Coverage 2.42
Cash Conversion 85.12%
Profit Quality 287.48%
Current Ratio 1.57
Quick Ratio 1.57
Altman-Z 1.85
F-Score8
WACC8.18%
ROIC/WACC0.63
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%187.5%
EPS Next Y38.55%
EPS Next 2Y56.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.43%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%-2.41%
Revenue Next Year4.22%
Revenue Next 2Y9.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.18%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year81.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.48%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y16.06%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%